Home โบ Triglycerides
Triglycerides clinical trials recruiting in the U.S.
9 studies for Triglycerides are recruiting participants at sites across the United States.
Triglycerides are a type of fat in your blood. Having a high level may raise the risk of heart disease, especially in women. Learn how to lower it.
Cities with the most studies
By state
- California5 studies
- Florida5 studies
- Georgia3 studies
- Illinois3 studies
- Indiana3 studies
- New York5 studies
- North Carolina3 studies
- Texas3 studies
Recently updated studies
A Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglyceridemia
RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Sep 22, 2026 ยท NCT07269210Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis
RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated Sep 21, 2026 ยท NCT06880770A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
RecruitingPhase 1
Ages 18 to 75 ยท All sexes ยท Updated Sep 18, 2026 ยท NCT07491172A Study to Assess the Safety, Tolerability and Efficacy of ION775
RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Sep 3, 2026 ยท NCT07604974Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol
RecruitingPhase 2
Ages 18 to 75 ยท All sexes ยท Updated Sep 2, 2026 ยท NCT07028749Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia
RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated Aug 12, 2026 ยท NCT06822790Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia
RecruitingPhase 1
Ages 18 to 70 ยท All sexes ยท Updated Jul 17, 2026 ยท NCT06451770A Mechanistic Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol
RecruitingPhase 2
Ages 18 to 75 ยท All sexes ยท Updated Nov 6, 2025 ยท NCT07199309Differential Thrombogenesis by EPA and DHA Mediated by HDL
RecruitingEarly phase 1
Ages 18 to 69 ยท All sexes ยท Updated Oct 1, 2025 ยท NCT06494488From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.